Stallergenes Greer Gets Hold Of Nestlé’s Palforzia For Peanuts
Peanut Allergy Therapy Has Been Commercial Flop
Nestlé has finally divested the peanut allergy business acquired in 2019 to much fanfare after the treatment spectacularly failed to live up to its blockbuster potential.
